Delivery Order SPE2DB20D1100-SPE2DB25FE1GB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,965.42 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Truvada (200 mg-300 mg tablets) in quantities of 30 units. This contract, valued at $1,307.50, operates under a firm fixed-price structure with an ultimate completion date of August 18, 2025. The award was competitively procured with no set-aside designation, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $13,263.60 and a firm fixed price structure. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,132.21 to supply Truvada 200 mg-300 mg tablets in quantities of 30 on June 25, 2025, with completion scheduled for June 26, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,959.85 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This firm fixed price delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involves no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,684.40 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive set-aside award under the DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $3,950.39 and an ultimate completion date of September 29, 2025. This non-competitive, firm fixed-price delivery order represents a pediatric antiretroviral pharmaceutical product to support federal medical supply requirements. The award was performed at AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $3,025.64. This non-set-aside contract was awarded on August 1, 2025, under a firm fixed price arrangement, with an ultimate completion date of August 4, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $8,241.75, is for the delivery of TRUVADA 200 MG-300 MG tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $33,003.17 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 22, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1GBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a contract ceiling value of $8,526.60. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The current award for Truvada, an antiretroviral medication, reflects the company's established role as a critical pharmaceutical vendor serving the Defense Health Agency and other federal healthcare systems through competitively awarded delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/26/25 |